Le Lézard
Classified in: Health, Science and technology

Nanomedical Diagnostics Announces Office Move to Accommodate Company Growth


SAN DIEGO, Calif., Dec. 10, 2018 /PRNewswire-PRWeb/ -- Nanomedical Diagnostics, leading producer of graphene biosensors for pharmaceutical and biotherapeutics research, announces a headquarters relocation to 9640 Towne Centre Drive, Suite 100, effectively tripling its space from 5,200 to 16,500 square feet.

"This past year has seen exponential growth, both domestically and internationally, for the sales of our drug discovery platforms. We're in the great position of having to move to a new space to accommodate expanded production and R&D," says Nanomedical Diagnostics CEO, Ross Bundy. "Our new building enables better operational efficiencies for our production lines and brings departments that were formerly separated in different locations together under one roof. This allows for better collaboration and innovation as we launch new products and grow our staff."

The company's move places it in the heart of the biotech sector in San Diego, providing closer proximity to key customers, as well as additional amenities such as large meeting rooms, a reception area, and exercise facilities. The versatile building is equipped to support a large R&D laboratory, shipping and delivery staging, expanded production capacity, and additional office staff.

"2019 promises to be an exciting year for the company," continues Mr. Bundy. "We're launching a new high-throughput drug discovery product early in the year and are in the process of hiring in all departments to support increased sales. We are also expanding our line of industrial OEM graphene sensors for use by partners in diverse industries and are thrilled to find a space that can accommodate our projected growth over the next few years."

Nanomedical Diagnostics' official move date is December 10, 2018.

About Nanomedical Diagnostics

Nanomedical Diagnostics ("Nanomed") is a life science company based in San Diego, CA. As the world's leading manufacturer and developer of next-generation graphene biosensors, Nanomed's mission is to transform the healthcare industry with innovative new products that enable cutting-edge life science research, drug discovery applications, and portable diagnostic and health monitoring platforms.

 

SOURCE Nanomedical Diagnostics, Inc.


These press releases may also interest you

at 12:59
Fusion Academy, the world's most personalized school with one-to-one classes to match students' pace and preference, is pleased to announce its 2024 Spring Virtual College Week, taking place from April 22 to April 25. This unique online program is...

at 12:55
Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of its client S&L Computer Services, Inc. to Cyber Advisors (a portfolio company of Goldner Hawn). The acquisition...

at 12:45
Beaverlab today announced the launch of a Kickstarter campaign for its new Excope DT1 camera. Excope DT1 is the world's lightest, portable super-telephoto camera for photos and videos. It is versatile, relieving photographers from the hassle of...

at 12:14
Anodot publishes its annual Cloud Cost Optimization Report, delivering insights from customer data and analysis of news and trends within the FinOps sector to prepare cloud users for 2024....

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:05
Phenom today announced IAMPHENOM ? the human resources event for talent acquisition, talent management, CHROs, HRIS and executives ? has sold out with record-breaking registrations and is reaching maximum capacity. Waitlisting is now available. The...



News published on and distributed by: